|
Market Closed -
Nasdaq
16:00:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 11.33 USD | +0.44% |
|
+2.44% | -44.35% |
| 09-29 | Keros Therapeutics Expects $20 Million Milestone Payment From Takeda | MT |
| 09-29 | Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda | CI |
Chart calendar Keros Therapeutics, Inc.
Upcoming events on Keros Therapeutics, Inc.
No events available
Past events on Keros Therapeutics, Inc.
| 2026-06-03 | Présentation aux Actionnaires / Analystes | 11:00 |
| 2026-06-03 | Annual General Meeting | 11:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,15 0,00 3363.3% | 3,55 32,1 -88.92% | 244 246 -0.76% | 15,6 | 13,7 | 44,7 |
|
EBITDA Million USD | Released Forecast Spread | -169 -166 -1.88% | -210 -204 -2.57% | 69,1 71,3 -3.1% | -110 | -87,2 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -170 -167 -1.51% | -211 -197 -6.9% | 67,6 61,6 9.75% | -121 | -154 | -138 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -153 -154 0.81% | -187 -175 -7% | 91,9 90,7 1.28% | -114 | -162 | -135 |
|
Net income Million USD | Released Forecast Spread | -153 -154 0.87% | -187 -163 -15.06% | 87,0 87,4 -0.41% | -110 | -147 | -133 |
|
EPS USD | Released Forecast Spread | -5,20 -5,24 0.78% | -5,00 -4,37 -14.32% | 2,30 2,16 6.32% | -5,54 | -6,24 | -4,66 |
| Announcement Date | 28/02/24 | 26/02/25 | 04/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,04 37,3 -91.85% | 211 56,6 272.93% | 18,2 4,21 331.22% | 14,3 4,22 237.78% | 0,39 3,66 -89.49% | 0,37 1,69 -78.25% | 0,00 0,71 - | 13,9 | 0,48 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -28,9 -28,2 -2.32% | -25,5 -28,7 11.23% | -30,5 -29,3 -4.12% | -13,5 | -38,5 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -53,3 -40,2 -32.48% | 152 -12,8 1290.37% | -39,8 -51,3 22.35% | -15,4 -50,5 69.52% | -29,3 -34,1 14.24% | -25,9 -33,4 22.56% | -30,9 -29,9 -3.52% | -24,3 | -41,5 | -48,0 | -49,0 | -55,0 | -59,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -45,7 -33,9 -35.06% | 158 -8,20 2032.81% | -32,9 -46,3 28.84% | -8,70 -43,3 79.88% | -25,0 -27,0 7.58% | -23,7 -29,9 20.72% | -28,7 -27,3 -5.34% | -24,5 | -40,0 | -47,0 | -49,0 | -54,0 | -59,0 |
|
Net income Million USD | Released Forecast Spread | -46,0 -22,0 -109.42% | 148 3,73 3878.85% | -30,7 -46,0 33.32% | -7,28 -42,7 82.96% | -23,5 -23,7 1.1% | -23,7 -27,6 14.1% | -28,7 -26,8 -7.23% | -20,3 | -39,2 | -47,0 | -49,0 | -54,0 | -59,0 |
|
EPS USD | Released Forecast Spread | -1,14 -0,64 -78.77% | 3,62 0,12 2827.86% | -0,76 -1,12 32.08% | -0,18 -1,02 82.35% | -0,86 -0,60 -43.6% | -1,21 -1,02 -18.3% | -1,45 -1,34 -8.21% | -1,02 | -1,93 | -2,23 | -1,65 | -1,75 | -1,81 |
| Announcement Date | 26/02/25 | 06/05/25 | 06/08/25 | 05/11/25 | 04/03/26 | 14/05/26 | 03/08/26 | - | - | - | - | - | - |
| Today |  | Earnings release - Q3 2026 | |
| 2026-10-27 | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Information meeting | 08:30 |
| Today | | Information meeting | 08:00 |
| 2026-10-27 | | Board of Directors Meeting | |
| 2026-10-27 | | Earnings release - Q3 2026 | |
| Today | | Information meeting | 14:00 |
| 2026-10-27 | | Extraordinary General Meeting | 22:00 |
| Today | | Présentation aux Actionnaires / Analystes | 09:00 |
Past sector events for Keros Therapeutics, Inc.
| 2026-10-26 | | Information meeting | 08:00 |
| Today | | Earnings presentation | 23:00 |
| Today | | Earnings presentation | 21:00 |
| 2026-10-26 | | Information meeting | 07:00 |
| 2026-10-26 | | Information meeting | 08:00 |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-23 | | Information meeting | 08:00 |
| 2026-10-23 | | Extraordinary General Meeting | 02:00 |
| 2026-10-22 | | Earnings release - Q3 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- KROS Stock
- Calendar Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
